Summit Therapeutics Inc. (SMMT)
NASDAQ: SMMT · Real-Time Price · USD
20.32
-0.28 (-1.36%)
At close: Mar 28, 2025, 4:00 PM
20.49
+0.17 (0.82%)
After-hours: Mar 28, 2025, 7:56 PM EDT
Summit Therapeutics Market Cap
Summit Therapeutics has a market cap or net worth of $14.99 billion as of March 28, 2025. Its market cap has increased by 373.65% in one year.
Market Cap
14.99B
Enterprise Value
14.58B
1-Year Change
373.65%
Ranking
Category
Stock Price
$20.32
Market Cap Chart
Since March 5, 2015, Summit Therapeutics's market cap has increased from $119.00M to $14.99B, an increase of 12,496.35%. That is a compound annual growth rate of 61.64%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Mar 28, 2025 | 14.99B | 13.91% |
Dec 31, 2024 | 13.16B | 619.43% |
Dec 29, 2023 | 1.83B | 113.79% |
Dec 30, 2022 | 855.60M | 225.45% |
Dec 31, 2021 | 262.90M | -32.00% |
Dec 31, 2020 | 386.60M | 653.61% |
Dec 31, 2019 | 51.30M | 203.55% |
Dec 31, 2018 | 16.90M | -87.66% |
Dec 29, 2017 | 137.00M | 30.60% |
Dec 30, 2016 | 104.90M | -21.83% |
Dec 31, 2015 | 134.20M | 12.77% |
View and export this data all the way back to 2015.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Eli Lilly and Company | 738.61B |
UnitedHealth Group | 472.03B |
Johnson & Johnson | 394.52B |
AbbVie | 363.15B |
Novo Nordisk | 305.46B |
AstraZeneca | 229.16B |
Abbott Laboratories | 226.88B |
Merck & Co. | 225.40B |